Literature DB >> 24711610

WIDEN: A tool for medical image management in multicenter clinical trials.

Stéphane Chauvie1,2, Alberto Biggi3, Alexandru Stancu1, Piergiorgio Cerello2, Anna Cavallo4, Federico Fallanca5, Umberto Ficola6, Michele Gregianin7, Ugo Paolo Guerra8, Agostino Chiaravalloti9, Orazio Schillaci9,10, Andrea Gallamini4.   

Abstract

Background It has been proposed that in clinical trials in which the therapeutic strategy is driven by functional imaging, central review of the images should be done in real time. Purpose We report our experience with a new tool for image exchange and review, called Web-Based Imaging Diagnosis by Expert Network (WIDEN), which we implemented for the HD0607 prospective multicenter Italian clinical trial in which Hodgkin lymphoma treatment was adapted based on results of an interim positron emission tomography (PET) scan performed after the first two cycles of chemotherapy. Methods We used WIDEN for general management of the clinical trial, site imaging qualification, image exchange, workflow control, blinded independent central review, inter-observer variability assessment, consensus creation, audit, and statistical analysis. Results As of February 2013, the interim PET was available for 512 patients; upon central review, 103 of the scans were judged to be positive and 409 to be negative. The median scan uploading and downloading times were 1 min, 25 s and 1 min, 55 s, respectively; the average and median times for diagnosis exchange were 47 h, 53 min and 37 h, 43 min, respectively. The binary concordance between pairs of reviewers (Cohen's kappa) ranged from 0.72 to 0.85. The 5-point scale concordance among all reviewers (Krippendorf's alpha) was 0.77. Conclusions WIDEN proved to be an effective tool for medical imaging exchange and online review. Data security, simplicity, feasibility, and prompt scan review were demonstrated. Central reviews were completed promptly.

Entities:  

Mesh:

Year:  2014        PMID: 24711610     DOI: 10.1177/1740774514525690

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  5 in total

1.  Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).

Authors:  Cristina Nanni; Elena Zamagni; Annibale Versari; Stephane Chauvie; Andrea Bianchi; Marco Rensi; Marilena Bellò; Ilaria Rambaldi; Andrea Gallamini; Francesca Patriarca; Francesca Gay; Barbara Gamberi; Michele Cavo; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-16       Impact factor: 9.236

2.  Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

Authors:  Cristina Nanni; Annibale Versari; Stephane Chauvie; Elisa Bertone; Andrea Bianchi; Marco Rensi; Marilena Bellò; Andrea Gallamini; Francesca Patriarca; Francesca Gay; Barbara Gamberi; Pietro Ghedini; Michele Cavo; Stefano Fanti; Elena Zamagni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-21       Impact factor: 9.236

3.  Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease.

Authors:  F R Mauro; S Chauvie; F Paoloni; A Biggi; G Cimino; A Rago; M Gentile; F Morabito; M Coscia; M Bellò; G M Sacchetti; D Rossi; L Laurenti; F Autore; M Campanelli; F Trastulli; E Nicolai; M Riminucci; G Gaidano; A Guarini; A Gallamini; R Foà
Journal:  Leukemia       Date:  2015-02-04       Impact factor: 11.528

Review 4.  The Strategies to Homogenize PET/CT Metrics: The Case of Onco-Haematological Clinical Trials.

Authors:  Stephane Chauvie; Fabrizio Bergesio
Journal:  Biomedicines       Date:  2016-11-15

Review 5.  Improving PET Imaging Acquisition and Analysis With Machine Learning: A Narrative Review With Focus on Alzheimer's Disease and Oncology.

Authors:  Ian R Duffy; Amanda J Boyle; Neil Vasdev
Journal:  Mol Imaging       Date:  2019 Jan-Dec       Impact factor: 4.488

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.